Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alpha
about
Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivoDendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccinationGRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppressionTargeted Cancer Therapy with Tumor Necrosis Factor-Alpha.
P2860
Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alpha
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Treatment of established lung ...... red to secrete human TNF-alpha
@ast
Treatment of established lung ...... red to secrete human TNF-alpha
@en
type
label
Treatment of established lung ...... red to secrete human TNF-alpha
@ast
Treatment of established lung ...... red to secrete human TNF-alpha
@en
prefLabel
Treatment of established lung ...... red to secrete human TNF-alpha
@ast
Treatment of established lung ...... red to secrete human TNF-alpha
@en
P2093
P2860
P1476
Treatment of established lung ...... red to secrete human TNF-alpha
@en
P2093
F M Marincola
L B Cheshire
N P Restifo
S A Rosenberg
S Ettinghausen
P2860
P304
P407
P577
1994-04-01T00:00:00Z